Antigen presenting cells (APCs) are required to present allergen and activate allergen specific T cells. Some populations of APCs express the high affinity IgE receptor (FcepsilonRI) and its expression can increase the efficiency of antigen presentation by 1000-fold. Given the critical importance of DCs in the initiation of allergic immune responses, we sought to examine FcepsilonRI expression by human DC subsets. We thus examined FcepsilonRI expression in the DC1 and DC2 populations, which are known to bias towards a Th1 and Th2 response, respectively. FcepsilonRI was expressed by both the precursor DC1 (pDC1) and pDC2 cells, as well as by mature tissue DC1 and DC2 cells. FcepsilonRI expression was significantly greater in allergic asthmatic subjects than in non-atopic controls. pDC1 and pDC2 expression of FcepsilonRI was highly correlated to serum IgE concentration. In a separate study, we further examined the relationship of DC expression of FcepsilonRI to IgE by dropping serum IgE concentration through the use of omalizumab (anti-IgE). During a clinical trial of omalizumab in allergic rhinitis subjects we serially examined FcepsilonRI expression in pDC1 and pDC2 cells. Omalizumab caused a significant drop in both pDC1 and pDC2 expression of FcepsilonRI, whereas there was no significant change in the placebo group. Omalizumab decreased FcepsilonRI expression by 52% and 83% for pDC1 and pDC2 cells, respectively. Furthermore, the decrease in FcepsilonRI expression was highly correlated with the drop in serum IgE, suggesting a direct relationship between the two variables. The results of both studies support the conclusion that serum IgE is a major factor driving FcepsilonRI expression by DCs. These data support the concept that novel therapeutic approaches directly targeted at FcepsilonRI expression would affect both the sensitization and effector phases of the allergen specific immune response.
| Liu, Rebecca Berlant; Engels, Boris; Schreiber, Karin et al. (2013) IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner. Proc Natl Acad Sci U S A 110:8158-63 |
| Liu, Rebecca B; Engels, Boris; Arina, Ainhoa et al. (2012) Densely granulated murine NK cells eradicate large solid tumors. Cancer Res 72:1964-74 |
| Prussin, Calman; Metcalfe, Dean D (2006) 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 117:S450-6 |
| Fritsch, Ruth D; Shen, Xinglei; Illei, Gabor G et al. (2006) Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum 54:2184-97 |
| Garvey, Tara L; Dyer, Kimberly D; Ellis, John A et al. (2005) Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice. J Immunol 175:4735-44 |
| Foroughi, Shabnam; Prussin, Calman (2005) Clinical management of eosinophilic gastrointestinal disorders. Curr Allergy Asthma Rep 5:259-61 |
| Prussin, Calman; Metcalfe, Dean D (2003) 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 111:S486-94 |
| Prussin, Calman; Griffith, Daniel T; Boesel, Kevin M et al. (2003) Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol 112:1147-54 |
| Foster, Barbara; Metcalfe, Dean D; Prussin, Calman (2003) Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma. J Allergy Clin Immunol 112:1132-8 |
| Metcalfe, Dean D (2003) Introduction: what are the issues in addressing the allergenic potential of genetically modified foods? Environ Health Perspect 111:1110-3 |
Showing the most recent 10 out of 17 publications
